Clinical Trial Asia Summit 2010, Bangaluru

Clinical Trial Asia Summit 2010, Bangaluru

Tech Observer exhibited Clinical Trial Asia Summit from August 19, 2010 to August 20, 2010. The Agenda of the summit was to improve clinical practice and trial success rates with improved technologies, strategies and alliance management.

CTAS 2010 examined the current issues faced in clinical trials operations, addressing the risks, timeline and budget stipulations, while effectively tackling key challenges in overcoming trials agreement and site contract arbitration problems.

This summit discussed the operational element of trial site management, strategic partnership with CROs and SMOs, patient, talent & investigators management in order to improve & optimise the overall drug development effectiveness and ROI. Discover on how to implement and benefit from electronic data management & monitoring cost effectively. The conference aimed to provide a detailed analysis of what it takes to conduct clinical trials from a biopharmaceuticals and vaccines perspective in India and China and also addressing risk/benefit balance, anecdotal experiences of the multinational pharmaceutical industry in India and China, selection and role of CROs, logistics of operations, clinical trials management, government policies and pharmacovigilance.

Key Speakers Included:

1. Akhilesh Sharma, Vice President & Global head Clinical management & Global Pharmacovigilance, Dr. Reddy’s

2. Bakulesh Khamar, Executive Director – Research, Cadila

3. Amol Pendse, Clinical Operations Manager, Bio South Asia Clinical R & D, Medical Affairs Biologicals Department, GlaxoSmithKline

4. Radhika  Bobba, Director Medical Services, Stempeutics Research, Partner & Founder, Anhvita BioPharma Consulting

5. S.K.Bhattacharya, Medical Officer, Depart of Communicable Diseases, WHO (World Health Organisation)

6. Tarun Puri, Medical Advisor, Eli Lilly

7. Shashidhar Rao, India Operations Head (IID and IA&R), Novartis

8. Deven Parmar, Vice President - Clinical Research & Pharamacovigilance, Wockhardt

9. Mohan Bangalore, Executive Director & Head , R&D Operations-India, Bristol-Myers Squibb (BMS)

10. Arun Bhatt, President, Clininvent Research

11. Rashmi Sidharthan, Associate Director - Life Science Technology, G7 SYNERGON

12. Mandeep S. Oberoi, President & CEO, Clintrials Research

13. Yamin ’Mo’ Khan, Executive Vice President, Clinical Development, Pharma-Olam (U.K)

14. Parminder Kaur, Managing Director, RegPak BioPharma Consulting, (Netherlands)

15. Zinobia Madan, Founder & Managing Director, ClinOma Healthcare

16. Ramesh Jagannathan, Director-Clinical Research, AstraZeneca (India)

17. Deepti Sanghavi, Medical Advisor - Clinical Research, Wockhardt Limited

18. Roopa Basrur, Associate Director - Clinical Writing and Document Quality, Pfizer

19. Larisa Nagra  Singh,General Manager and Project Director, Voisin Consulting Life Science

20. Marcus Hompesch, President – CEO, Profil Institute - Clinical Research, (USA)

21. Srini Kalluri, President & CEO, PercipEnz Technologies, (USA)

22. Sanjeev  Gupta, Head of Operations, Unithink (Belguim)

23. Milind Antani, Head-Pharma LifeSciences group, Nishith Desai Associates

24. Darshan Bhatt, Consultant, Patient Safety and Pharmacovigilance

25. Thuppil Venkatesh, Prof.St.John's Medical College & Principal Advisor, Quality Council of India

26. Mala Srivastava, Partner, Nextvel Consulting

27. Lakshmanan  Sathappan, Regulatory Affairs Manager, PharmaLeaf

28. Shivamurthy Nanjundappa, Director - Clinical Research and Business Development, Quartesian Clinical Research .

Tech Observer being a global CRO, this summit posed a great opportunity as it included all the big players and therefore the chance to showcase all the services, it majors in.

 

For media relations or any other enquiries regarding press releases, please contact:

Email: pr@tech-observer.com